Hydroxyethyl starch and granulocyte transfusions: considerations of utility and toxicity profile for patients and donors

Randomised trials of 6 % tetrastarch (hydroxyethyl starch 130/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis

(2013) Amit Patel et al.   INTENSIVE CARE MEDICINE

Fluid resuscitation with 6 % hydroxyethyl starch (130/0.4 and 130/0.42) in acutely ill patients: systematic review of effects on mortality and treatment with renal replacement therapy

(2013) David J. Gattas et al.   INTENSIVE CARE MEDICINE

Association of Hydroxyethyl Starch Administration With Mortality and Acute Kidney Injury in Critically Ill Patients Requiring Volume Resuscitation

(2013) Ryan Zarychanski et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis

(2013) N. Haase et al.   BMJ-British Medical Journal

Effects of fluid resuscitation with synthetic colloids or crystalloids alone on shock reversal, fluid balance, and patient outcomes in patients with severe sepsis

(2012) Ole Bayer et al.   CRITICAL CARE MEDICINE

Effect of hydroxyethyl starch on bleeding after cardiopulmonary bypass: A meta-analysis of randomized trials

(2012) Roberta J. Navickis et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Hydroxyethyl Starch 130/0.42 versus Ringer's Acetate in Severe Sepsis

(2012) Anders Perner et al.   NEW ENGLAND JOURNAL OF MEDICINE

Hydroxyethyl Starch or Saline for Fluid Resuscitation in Intensive Care

(2012) John A. Myburgh et al.   NEW ENGLAND JOURNAL OF MEDICINE

Impact of the mobilization regimen and the harvesting technique on the granulocyte yield in healthy donors for granulocyte transfusion therapy

(2012) Junko Ikemoto et al.   TRANSFUSION

Association of 6% hetastarch resuscitation with adverse outcomes in critically ill trauma patients

(2011) Matthew E. Lissauer et al.   AMERICAN JOURNAL OF SURGERY

Pentastarch 10% (250 kDa/0.45) is an independent risk factor of acute kidney injury following cardiac surgery*

(2009) Jean-Philippe Rioux et al.   CRITICAL CARE MEDICINE

Randomized phase III study of granulocyte transfusions in neutropenic patients

(2008) M G Seidel et al.   BONE MARROW TRANSPLANTATION

The determinants of granulocyte yield in 1198 granulocyte concentrates collected from unrelated volunteer donors mobilized with dexamethasone and granulocyte-colony-stimulating factor: a 13-year experience

(2008) Karen Quillen et al.   TRANSFUSION